-42
NPS Score
VS
Exelixis
- EMPLOYEE
PARTICIPANTS - 35
- TOTAL
RATINGS
Sarepta Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 34
- TOTAL
RATINGS
Exelixis vs Sarepta Therapeutics
Compare Exelixis versus Sarepta Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 35 employees and customers of Exelixis and 34 employees and customers of Sarepta Therapeutics.
Exelixis
Exelixis's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Exelixis. Their current market cap is $6.11B.
Sarepta Therapeutics
Sarepta Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Sarepta Therapeutics. Their current market cap is $11.66B.
2.7/5
Product Quality
3.7/5
3.2/5
Pricing
3.7/5
3.1/5
Customer Service
5/5
| 29% | Promoters |
|---|---|
| 0% | Passive |
| 71% | Detractors |
-9
NPS Score
| 36% | Promoters |
|---|---|
| 19% | Passive |
| 45% | Detractors |
Net Promoter Score
Winner by 33
See how Exelixis compares to its competitors
See how Sarepta Therapeutics compares to its competitors
Working at Exelixis vs Working at Sarepta Therapeutics
32 / 100
CEO Rating
79 / 100
CEO Rating
Winner by 47%
Exelixis
Exelixis doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Sarepta Therapeutics
Employees at Sarepta Therapeutics rate their CEO, Douglas Ingram, 79/100. This score is 47% higher than the scores of Exelixis' CEO, Michael Morrissey.